5 news items
Gossamer Bio Provides Updated Seralutinib TORREY Open-Label Extension Data At The American Thoracic Society 2024 International Conference, Which Takes Place May 17-22
GOSS
14 May 24
(PH-ILD), will present updated seralutinib TORREY open-label extension data at the American Thoracic Society 2024 International Conference, which takes place May 17-22in San Diego, California.
Gossamer Bio to Provide Updated Seralutinib TORREY Open-Label Extension Data at the American Thoracic Society 2024 International Conference
GOSS
14 May 24
TORREY open-label extension data at the American Thoracic Society 2024 International Conference, which takes place May 17
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GOSS
7 May 24
Society (ATS) 2024 International Conference taking place in San Diego. Details below
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
GOSS
6 May 24
to a Benefit Corporation in Italy, the US, and France, Chiesi's commitment to create shared value for society as a whole is legally binding and central
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan to its Board of Directors
GOSS
12 Mar 24
, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung Transplantation. Dr
- Prev
- 1
- Next